The authors frame early life stress (ELS) as adverse experiences during childhood that produce long-term psycho-physiological pathologies and accelerate biological aging. In this preclinical report, the relationship between ELS and the gut microbiome is the focus: ELS-associated changes in gut microbial communities are described as gut dysbiosis, a state the authors link to later-life pathologies in their model.
The article is presented as a preprint and therefore has not been peer reviewed. This status is explicitly noted by the authors and the posting platform.
The work uses a maternal separation model of neonatal adversity to model ELS. The population described in the source comprises middle-aged rodents with a history of neonatal maternal separation. The source text identifies this model and age group but does not provide experimental details (for example, species, strain, numbers, or timing) in the accessible abstract. Those methodological details were not reported in the source.
The intervention reported is nicotinamide treatment. The authors note prior observations in the same maternal separation model that nicotinamide alleviated several ELS-associated pathologies; the source does not enumerate those pathologies or provide quantitative data in the accessible abstract. The current report extends this line of investigation to examine the effect of nicotinamide on the gut microbiome of animals previously exposed to neonatal maternal separation.
The central result communicated in the source is that nicotinamide-driven amelioration of gut dysbiosis was observed in middle-aged rodents with a history of neonatal maternal separation. The source frames this as a reported outcome but does not include specific microbiome metrics, taxa-level changes, statistical results, or effect sizes in the abstract. Therefore, while the high-level finding is clearly stated, the underlying experimental evidence (methods, analyses, numeric outcomes) was not reported in the accessible portion of the source.
The article is a preprint posted on bioRxiv and has the DOI provided in the source metadata. The authors have declared no competing interests. Reported funders include the Department of Atomic Energy (grants RTI4015, RTI4003), the Sree Ramakrishna Paramahamsa Research Grant for Translational Biomedical Research, a J.C. Bose Fellowship (ANRF), and the Wellcome Trust/DBT India Alliance (grant IA/E/18/1/504310).
The accessible source text describes the model, the intervention, and the high-level outcome but omits many experimental details necessary to assess reproducibility and translational relevance. Specifically, the abstract and metadata available do not report:
Because these elements are not included in the source abstract, they cannot be summarized or interpreted here. The reader should consult the full preprint PDF or supplementary material linked by the authors for complete methods and results.
Within the limits of the information presented, the report suggests that nicotinamide may reverse or mitigate ELS-associated alterations in gut microbial composition in a rodent maternal separation model, observed in middle age. The finding supports further investigation into the interaction between ELS, aging, the gut microbiome, and metabolic or neurobehavioral outcomes, but the preprint status and the absence of methodological and quantitative details in the accessible abstract mean that confirmation, replication, and mechanistic work will be required before considering clinical implications.
The source provides links to the full preprint PDF and supplementary material. For experimental protocols, numerical results, and in-depth analyses cited by the authors, consult the full-text preprint at the DOI and the supplementary files linked on the bioRxiv page. The abstract intentionally limits detail; the full manuscript is the appropriate next source for researchers seeking methods and raw data.